cyclin D3 Background Information The proliferation of eukaryotic cells is controlled at specific points in the cell cycle, particularly at the G1 to S and the G2 to M transitions. It is well established that the Cdc2 p34-cyclin B protein kinase plays a critical role in the G2 to M transition while cyclin A associates with Cdk2 p33 and functions in S phase. Considerable effort directed towards the identification of G1 cyclins has led to the isolation of cyclin D, cyclin C and cyclin. Of these, cyclin D corresponds to a putative human oncogene, designated PRAD1, which maps at the site of the Bcl-1 rearrangement in certain lymphomas and leukemias. Two additional human type D cyclins, as well as their mouse homologs, have been identified. Evidence has established that members of the cyclin D family function to regulate phosphorylation of the retinoblastoma gene product, thereby activating E2F transcription factors.
cyclin D3 (18B6-10) Product Citations
See how others have used cyclin D3 (18B6-10): sc-453 antibody and or cyclin D3 (18B6-10) antibody conjugates.
18 total citations
Loading citations.
cyclin D3 (18B6-10)
Click on image to enlarge
Western blot analysis of cyclin D3 expression in nuclear extract prepared from phorbol ester-treated Jurkat cells (A) and untreated Jurkat nuclear extract (B). Antibodies tested include cyclin D3 (18B6-10): sc-453 (A) and cyclin D3 (H-292): sc-755 (B).
cyclin D3 (18B6-10): sc-453. Western blot analysis of cyclin D3 expression in non-transfected: sc-117752 (A) and mouse cyclin D3 transfected: sc-119546 (B) 293T whole cell lysates.
cyclin D3 (18B6-10): sc-453. Western blot analysis of cyclin D3 expression in Jurkat whole cell lysate.
goat anti-rat IgG-HRP: sc-2032. Western blot analysis of cyclin D3 expression in PMA treated Jurkat nuclear extract. Antibody tested: cyclin D3 (18B6-10): sc-453.
goat anti-rat IgG-HRP: sc-2303. Western blot analysis of cyclin D3 expression in PMA treated Jurkat nuclear extract. Antibody tested: cyclin D3 (18B6-10): sc-453.